Proteome Sciences plc (PRM) Ordinary 1p
0.06p
(2.21%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.06p
(2.21%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.06p
(2.21%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
2.72p
3.20p
5.03p
£8.03 million
2.72p
2.36p
2.30p
n/a
0.06p (2.16%) Previous:
0.06p
13,833
n/a
75,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 5.03 | 7.78 |
| Profit before tax (£m) | (2.42) | 1.25 |
| Adjusted EPS (p): | (0.83) | 0.45 |
| P/E ratio | n/a | 7.80 |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | 2,150.00 |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Proteome Sciences swings to EBITDA loss, CEO steps down
13 September 2024 12:02
-
Proteome Sciences secures contract win with US biopharmaceutical firm
26 April 2024 09:45
-
Proteome launches San Diego lab operations
2 January 2024 14:44
-
Interim Results and Directorate Change
13 September 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.